Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 1, 2011
Grant Date -
Aug 23, 2007
app pub date -
Dec 21, 2006
filing date -
Dec 21, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases. A particular combination comprises R,R-glycopyrrolate, rolipram, and budesonide, or physiologically acceptable salts thereof, wherein dosage amounts are such that a synergistic therapeutic effect is achieved.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully